Role of glucosamine in osteoarthritis

Current Orthopaedics

Volumn 21, Issue 5, 2007, Pages 386-389

  Thakral, R ^a   Debnath, U K ^b   Dent, C ^b  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Action; Arthritis; Cartilage; Glucosamine

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOSAMINE;

ANALGESIA; ARTICLE; BLOOD PRESSURE; CARTILAGE; CLINICAL PRACTICE; DEPRESSION; DISABILITY; DISEASE ACTIVITY; FOLLOW UP; HUMAN; JOINT CAVITY; KNEE OSTEOARTHRITIS; MUSCULOSKELETAL PAIN; OSTEOARTHRITIS; PRIORITY JOURNAL; SIDE EFFECT; SURGICAL APPROACH; TREATMENT INDICATION; URINARY TRACT INFECTION; VERTIGO;

EID: 36349018802     PISSN: 02680890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cuor.2007.04.002     Document Type: Article

References (33)

1. Hamerman D. The biology of osteoarthritis. N Engl J Med 320 (1989) 1322-1330
2. Briffa J. A critical review of the use of glucosamine sulphate in the treatment of osteoarthritis. Int J Alt Comp Med 15 (1997) 15-16
3. Baker C.L., and Ferguson C.M. Future treatment of osteoarthritis. Orthopaedics 28 Supp 2 (2005) 227-234
4. Hauselmann H.J. Nutripharmaceuticals for osteoarthritis, best practice and research. Clin Rhematol 15 4 (2001) 595-607
5. Phoon S., and Manolios N. Glucosamine A nutraceutical in osteoarthritis. Aus Fam Physician 31 6 (2002) 539-541
6. Kelly G.K. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Alternative Med Rev 3 1 (1998) 27-39
7. Lahiji A., Sohrabi A., Hungerford D.S., and Frondoza C.G. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 51 4 (2000) 586-595
8. Setnikar I., and Rovati L.C. Absorption, distribution, metabolism and excretion of glucosamine sulfate. Rev Arzneimittelforschung 51 9 (2001) 699-725
9. Monauni T., Zenti M.G., Cretti A., Daniels M.C., Targher G., Caruso B., Caputo M., McClain D., Del Prato S., Giaccari A., Muggeo R.C., Bonora E., and Bonadonna R.C. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 49 6 (2000) 926-935
10. Pouwels M., Jacobs J.R., Span P.N., Lutterman J.A., Smits P., and Tack C.J. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab. 86 5 (2001) 2099-2103
11. Anderson J.W., Nicolosi R.J., and Borzelleca J.F. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol 43 (2005) 187-201
12. Regnister J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., Giacovelli G., Henrotin Y., Dacre J.E., and Gossett C. Long term effects of glucosamine sulphate on osteoarthritis progression : a randomised, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
13. Pavelka K., Gatterova J., Olejarova M., Machacek S., Giacovelli G., and Rovati L.C. Glucosamine sulphate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162 18 (2002) 2113-2123
14. Persiani S., Roda E., Rovati L.C., Locatelli M., Giacovelli G.P., and Roda A. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthr Cartilage 13 (2005) 1041-1049
15. Noyszewski E.A., Wroblewski K., Dodge G.R., Kudchodkar S., Beers J., Sarma A.V., and Reddy R. Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfate in articular cartilage explants. Arthr Rheum 44 (2001) 1089-1095
16. Bassleer C., Rovati L.C., and Franchimont P. Stimulation of proteoglycans production by glucosamine sulphate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthr Cartilage 6 6 (1998) 427-434
17. Dodge G.R., and Jimenez S.A. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase- 3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthr Cartilage 11 6 (2003) 424-432
18. Uldry M., Ibberson M., Hosokawa M., and Thorens B. GLUT2 is a high affinity glucosamine transporter. FEBS Lett 524 1-3 (2002) 199-203
19. Takamiya Y., Friedlander R.M., Brem H., Malick A., and Martuza R.L. Inhibition of angiogenesis and growth of human nervesheath tumors by AGM-1470. J Neurosurg 78 3 (1993) 470-476
20. Bruyere O., Pavelka K., Rovati L.C., Deroisy R., Olejarova M., Gatterova J., Giacovelli G., and Reginster J.Y. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause 11 2 (2004) 134-135
21. Sokoloff L. Osteoarthritis as a remodeling process. J Rheumatol 14 (1987) 7-10
22. Owens S., Wagner P., and Vangsness Jr. C.T. Recent advance in glucosamine and chondritin supplementation. J Knee Surg 17 4 (2004) 185-193
23. Chan P.S., Charon J.P., and Orth M.W. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol 33 7 (2006) 1329-1340
24. Lippeillo L. Glucosamine and chondritin sulphate: biological response modifier of chondrocytes under simulated conditions of joint stress. Osteoarthr Cartilage 11 5 (2003) 335-342
25. Qiao B., Padilla S.R., and Benya P.D. Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. J Biol Chem 280 17 (2005) 17562-17571
26. Varghese S, Theprungsirikul P, Sahani S, Hwang N, Yarema KJ, Elisseeff JH. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthritis Cartilage 2006; July 15 (Epub ahead of print).
27. Uitterlinden E.J., Jahr H., Koevoet J.A., Jemmiskens Y.M., Bierma-Zeinstra S.M., Degroot J., Verhaar J.A., Weinans H., and van Osch G.J. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthr Cartilage 14 3 (2006) 250-257
28. McAlindon T.E., LaValley M.P., Gulin J.P., and Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. J Am Med Associat 283 11 (2000) 1469-1475
29. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y., and Reginster J.Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensivemeta-analysis. Arch Intern Med 163 13 (2003) 1514-1522
30. Towheed T.E., Maxwell L., Anastassiaides T.P., Shea B., Houpt J., Robinson V., Hochberg M.C., and Wells G. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 18 2 (2005) CD002946
31. Chard J., and Dippe P. Glucosamine for osteoarthritis: magic, hype, or confusion?. Bri Med J 322 (2001) 1439-1440
32. Bazian Ltd. Glucosamine for osteoarthritis. Evidence-based Healthcare Pub Health 9 (2005) 322-331
33. Hughes R., and Carr A. A randomised, double-blind, placebo controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatomlogy 41 (2002) 279-284